[go: up one dir, main page]

Gushchin et al., 1986 - Google Patents

Effect of Vespa orientalis venom fractions on rat mast cells and human basophils.

Gushchin et al., 1986

Document ID
16417609119951188052
Author
Gushchin I
Zebrev A
Miroshnikov A
Tuychibayev M
Publication year
Publication venue
PATOL. FIZIOL. EKSP. TER.

External Links

Continue reading at scholar.google.com (other versions)

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/16Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/19Cytokines; Lymphokines; Interferons
    • A61K38/21Interferons [IFN]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K35/00Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells

Similar Documents

Publication Publication Date Title
TW427905B (en) Aqueous pharmaceutical composition of nerve growth factor
CA2005811A1 (en) Cosmetic composition
CA2346997A1 (en) Cytotoxic lymphocyte maturation factor and monoclonal antibodies directed thereto
IL85746A0 (en) Preparation of t cells and t cell membrane for use in autoimmune diseases
DE69213421D1 (en) Process for the preparation of an activated factor VII concentrate with a high purity
CA2017025A1 (en) Tumor necrosis factor binding protein ii, its purification and antibodies thereto
IL154797A0 (en) Vascular endothelial cell growth factor that is unaccompanied by associated native glycosylation, pharmaceutical composition containing it and use thereof in the manufacture of a medicament for treating trauma affecting the vascular endothelium
ATE45498T1 (en) IMMUNOMODULATING DRUG BASED ON FC FRAGMENTS OF HUMAN IG GS.
DK132284D0 (en) IMMUNOGLOBULIN-G-CONTAINING FRACTION
KR890700032A (en) How to treat iron hyperplasia
TW275066B (en)
KR900007424A (en) Method of using N-acetylglucosamine as a cytoprotective agent and composition thereof
EP0348184A3 (en) Cosmetic composition
AR019852A1 (en) INSULIN ANALOGS, PROCEDURE FOR PREPARATION, PRECURSOR OF INSULIN ANALOGS, DNA SEQUENCE CODING THEM, VEHICLE OF FUNCTIONAL EXPRESSION IN BACTERIA AND YEAST, GUEST CELL, PHARMACEUTICAL COMPOSITION, INJECTABLE INJECTATION OF INJECTION
Gushchin et al. Effect of Vespa orientalis venom fractions on rat mast cells and human basophils.
Patriarca et al. A comparative study of the intracellular Ca++ movements in white and red muscle
ES8507000A1 (en) Purification of antihemophilia factor viii by precipitation with zinc ions.
IL82654A0 (en) Treatment of basal cell carcinoma intralesionally with recombinant human alpha interferon
EP0219073A2 (en) Stabilization of interferons
Deriugina et al. Cells that maintain long-term hematopoiesis in culture do not possess the capacity for regeneration following irradiation
Burov et al. Formation of experimental alcoholism in a population of crossbred rats
Gilot et al. Evolution of tick populations(Ixodidae and Argasidae) in relation to environment artificialisation process in the French Alps, epidemiology.
Mamontov et al. Cell proliferation in mouse tissues after thymectomy and the administration of T-activin
Negri Structure-activity relationships of the δ-opioid selective agonists, deltorphins
Kozlov et al. Antibody formation and B-cell migration from bone marrow to spleen in mice under conditions of stimulation and suppression of erythropoiesis